Mitsubishi Chemical picks Bain

Mitsubishi Chemical has given Bain first refusal right to negotiate purchase of subsidiary, Nikkei says
Mitsubishi Chemical Group has given the U.S. investment fund Bain Capital the right of first refusal to negotiate the purchase of its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, the Nikkei reported on Monday.
Mitsubishi Chemical Eyes $3.2 Billion Deal with Bain Capital
Mitsubishi Chemical Group is stepping up its efforts to streamline operations by entering negotiations with U.S. investment fund Bain Capital to sell its pharmaceutical arm, Mitsubishi Tanabe Pharma.
Bain Capital Reportedly In Talks To Buy Mitsubishi Chemical's Pharma Unit For $3.2 Bln
Investment firm Bain Capital is in talks to acquire Mitsubishi Tanabe Pharma Corp., affiliated to Japan's Mitsubishi Chemical Group
Mitsubishi Chemical picks Bain as preferred bidder for pharma unit, sources say
Japan's Mitsubishi Chemical Group has picked U.S. investment fund Bain Capital as the preferred bidder for its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, in a deal that could value it at over $3 billion,
Mitsubishi Chemical to negotiate with Bain to sell drug unit
TOKYO -- Japan's Mitsubishi Chemical Group has granted a first-refusal right to U.S. investment fund Bain Capital for the purchase of its pharmaceutical subsidiary Mitsubishi Tanabe Pharma, Nikkei has learned. The deal could exceed 500 billion yen ($3.2 billion).
Bain Capital in Talks to Buy Mitsubishi Tanabe Pharma
Bain Capital is in talks to acquire Mitsubishi Chemical Group’s pharmaceutical business in a potential multibillion-dollar deal, a person familiar with the matter said.
Mitsubishi Chemical picks Bain as preferred bidder for subsidiary, Nikkei says
Mitsubishi Chemical Group picked U.S. investment fund Bain Capital as the preferred bidder for its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, the Nikkei reported on Monday. The company is likely to sell its Tanabe Mitsubishi Pharma unit to Bain Capital for more than 500 billion yen ($3.
Grist2d
Mitsubishi cancels plans for a $1.3B chemical plant in Louisiana’s Cancer Alley
This coverage is made possible through a partnership between Grist and Verite News, a nonprofit news organization with a ...
WWNO6d
Win for activists as Mitsubishi halts plans to build chemical plant in 'Cancer Alley'
Much of the once-open land is now developed, but 67 acres will be spared for now after the Tokyo-based chemical company ...
Truthout7d
Plans for a Majorly Polluting Chemical Plant Nixed in Louisiana’s Cancer Alley
Geismar residents are surrounded by about a half-dozen large chemical facilities that emit harmful levels of air pollution.
Dividend Stocks To Consider In January 2025
As global markets continue to navigate the complexities of cooling inflation and strong earnings reports, major U.S. stock indexes have shown resilience with notable gains, particularly in value ...
Deep3d
NTT DATA Leverages All-Photonics Network for Remote Factory Monitoring
Solutions, and Mitsubishi Chemical Group have conducted a verification experiment aimed at reducing the burden on workers ...